Evidence map›Paper›PMID 40733114›Full record

ArticlePharmaceutics2025

A Novel Temozolomide-Myricetin Drug-Drug Cocrystal: Preparation, Characterization, Property Evaluations.

Hai-Xin Qin, Jie Wang, Jia-Hui Peng, Xia-Lin Dai, Cai-Wen Li, Tong-Bu Lu, Jia-Mei Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hai-Xin QinSchool of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China.
Jie WangBionna (Beijing) Medicine Technology Co., Ltd., Beijing 102600, China.
Jia-Hui PengSchool of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China.
Xia-Lin DaiSchool of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China.
Cai-Wen LiSchool of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China.
Tong-Bu LuInstitute for New Energy Materials and Low Carbon Technologies, School of Materials Science and Engineering, Tianjin University of Technology, Tianjin 300384, China.
Jia-Mei ChenSchool of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China.

Funding

National Natural Science Foundation of China 22271220
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

crystal structuredissolutiondrug-drug cocrystalmyricetinstabilitytabletabilitytemozolomide

Identifiers

PMID40733114
PMCPMC12299715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.